AposHealth® (previously AposTherapy®) is a global leader in the identification and treatment of gait-related conditions.
The AposHealth®’s foot-worn “Apos3” device is FDA-cleared for treating knee osteoarthritis, to help temporarily reduce knee pain and improve lower extremity function during activities of daily living. It is also a non-FDA cleared wellness device which can help patients live well with other gait-related conditions such as chronic low back and hip pain.
With a mission to advance global health through the power of movement, AposHealth®’s latest business unit AposIQ, combines innovative technology, data science and over a decade of experience in gait modification to determine the optimal way to adjust patients’ gaits over time.
Since 2005, AposHealth® has been making it possible for patients in the US, UK, and Israel, to develop better movement patterns and get back to doing the things they love.
Location: United States, New York
Member count: 51-200
Phone: +1 855-999-2767
Total raised: $11M
Founded date: 2004
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 17.02.2020 | Series A | $11M | aMoon Fund | - |